
Aaron Traywick, the 28-year-old CEO of biotech startup Ascendance Biomedical who made headlines when he injected himself with an untested …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

